$ETNB 89bio, Inc. Insider Trading Week 45/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in 89bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in 89bio, Inc. in week 45/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Naschitz Anat | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 10,327,777 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Option Exercise | C | 0.00 | 10,327,777 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,661,214 | 0 | 3,161,214 | 1.5 M to 3.2 M (+110.75 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | C | 0.00 | 1,661,214 | 0 | 3,161,214 | 1.5 M to 3.2 M (+110.75 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 | 0 to 1.5 M |
| Nov 13 2019 | ETNB | 89bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | P | 16.00 | 1,500,000 | 24,000,000 | 1,500,000 | 0 to 1.5 M |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Grunberg Gregory | Director | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | C | 0.00 | 366,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | C | 0.00 | 58,978 | 0 | 77,728 | 18.8 K to 77.7 K (+314.55 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Option Exercise | C | 0.00 | 366,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | P | 16.00 | 18,750 | 300,000 | 18,750 | 0 to 18.8 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | C | 0.00 | 58,978 | 0 | 77,728 | 18.8 K to 77.7 K (+314.55 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Hayden Michael R | Director | Buy | P | 16.00 | 18,750 | 300,000 | 18,750 | 0 to 18.8 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 11,916,667 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 1,916,787 | 0 | 2,491,787 | 575 K to 2.5 M (+333.35 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | Longitude Capital Partners III ... | 10% Owner | Buy | P | 16.00 | 575,000 | 9,200,000 | 575,000 | 0 to 575 K |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
| Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |